Epinephrine Bitartrate, Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Oct 14, 2016.

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-482-57
Dosage Form
Injection
Presentation
Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)
Initial Posting
Oct 14, 2016

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.